Cano Health, Inc.
CANOQ
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 684.43M | 716.03M | 788.07M | 766.75M | 866.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 684.43M | 716.03M | 788.07M | 766.75M | 866.91M |
| Cost of Revenue | 686.86M | 682.87M | 772.47M | 826.39M | 776.76M |
| Gross Profit | -2.43M | 33.16M | 15.60M | -59.64M | 90.15M |
| SG&A Expenses | 89.11M | 80.50M | 80.82M | 99.42M | 96.47M |
| Depreciation & Amortization | 18.37M | 24.87M | 26.74M | 27.25M | 27.22M |
| Other Operating Expenses | -- | 0.00 | -- | 62.00M | -- |
| Total Operating Expenses | 794.34M | 788.23M | 880.03M | 1.02B | 900.45M |
| Operating Income | -109.91M | -72.20M | -91.96M | -248.31M | -33.54M |
| Income Before Tax | -478.17M | -275.67M | -491.84M | -272.62M | -60.59M |
| Income Tax Expenses | 36.00K | 202.00K | -145.00K | -1.87M | -- |
| Earnings from Continuing Operations | -478.21M | -275.88M | -491.70M | -270.75M | -60.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 62.50M | 110.85M | 231.21M | 129.99M | 32.44M |
| Net Income | -415.71M | -165.03M | -260.49M | -140.75M | -28.15M |
| EBIT | -109.91M | -72.20M | -91.96M | -248.31M | -33.54M |
| EBITDA | -91.54M | -47.34M | -65.22M | -221.06M | -6.32M |
| EPS Basic | -90.46 | -54.43 | -91.87 | -51.25 | -11.74 |
| Normalized Basic EPS | -51.27 | 15.66 | 55.78 | -15.32 | -0.70 |
| EPS Diluted | -91.10 | -66.07 | -91.87 | -51.29 | -12.03 |
| Normalized Diluted EPS | -44.89 | 15.66 | 55.78 | -7.97 | -0.34 |
| Average Basic Shares Outstanding | 4.60M | 3.03M | 2.84M | 2.75M | 2.40M |
| Average Diluted Shares Outstanding | 5.25M | 3.03M | 2.84M | 5.28M | 5.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
